Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TNGX
#1588
Tango Therapeutics, Inc.
24.0
7
USD
+11.64%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+11.64%
Changement Mensuel
+38.89%
Evolution sur 6 mois
+175.40%
Changement Annuel
+1696.27%
Clôture Précédente
21.5
6
Open
24.0
6
Bid
Ask
Low
24.0
6
High
24.0
7
Volume
94
Marchés
Actions des Marchés US
Soins de Santé
TNGX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
21.38 M
87.71 M
88.2 M
106.72 M
108.11 M
142.69 M
—
Valuation ratios
Enterprise value
—
816.78 M
584.8 M
998.66 M
264.52 M
1.15 B
2.84 B
Price to earnings ratio
—
—
-5.94
-9.24
-2.6
-10.18
-24.46
Price to sales ratio
—
—
25.82
25.84
8.02
16.5
57.84
Price to cash flow ratio
—
—
-5.89
-8
-2.57
-7.41
-18.73
Price to book ratio
—
—
2.57
3.73
1.69
2.97
5.34
Enterprise value to EBITDA ratio
—
-14.26
-5.34
-8.94
-1.85
-10.57
-24.56
Profitability ratios
Return on assets %
—
-0.12
-0.25
-0.25
-0.41
-0.25
-0.33
Return on equity %
—
-0.17
-0.43
-0.4
-0.65
-0.29
-0.54
Return on invested capital %
—
-225.15
-608.39
-468.46
-702.71
-678.99
-655.15
Gross margin %
—
100
100
100
100
100
—
Operating margin %
—
-157.09
-446.79
-312.57
-346.09
-178.39
—
EBITDA margin %
—
-154.67
-440.32
-305.96
-340.15
-174.74
—
Net margin %
—
-157.21
-435.14
-278.54
-309.73
-162.85
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.1
12.1
6.76
7.54
6.98
16.32
36.21
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.11
0.05
0.09
0.12
0.17
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.24
-1.25
-1.2
-1.2
-1.23
EBIT per share
—
—
-1.26
-1.21
-1.33
-0.96
-1
EBITDA per share
—
—
-1.25
-1.18
-1.31
-0.94
-0.98
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.66
6.42
2.36
2.95
7.85
Net current asset value per share
—
—
4.27
3.66
2.44
3.05
8.19
Tangible book value per share
—
—
2.84
2.68
1.83
2.98
7.07
Working capital per share
—
—
3.64
3.18
2.09
2.86
7.16
Book value per share
—
—
2.84
2.68
1.83
2.98
7.07
Nouvelles
L’action Tango Therapeutics atteint un sommet historique de 22,21 $
Leerink relève l’objectif de cours de Tango Therapeutics sur les données PDAC
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Le président de Tango Therapeutics vend des actions pour 572.000$
L’action Tango Therapeutics atteint un sommet historique à 21,84 USD
Le président de Tango Therapeutics vend pour 241.000$ d’actions
L’action Tango Therapeutics atteint un sommet historique à 19,83 USD
L’action Tango Therapeutics atteint un sommet de 52 semaines à 17,64$
Tango Therapeutics stock hits 52-week high at $17.64
Stifel relève l’objectif de cours de Tango Therapeutics suite aux données PRMT5
Stifel raises Tango Therapeutics stock price target on PRMT5 data
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise (NASDAQ:TNGX)